Andere Sprachen HOOKIPA Pharma Inc.

Aktien

A2PGMT

US43906K1007

HOOK

Markt geschlossen - Nasdaq Andere Börsenplätze 21:59:52 30.05.2024			% 5 Tage	% 1. Jan.
0,7565 ^USD	+0,87 %		-27,26 %	-6,60 %

23.05.	HOOKIPA Pharma Inc. kündigt positive klinische Daten an, die auf der Jahrestagung 2024 der Amerikanischen Gesellschaft für Klinische Onkologie vorgestellt werden	CI
09.05.	HOOKIPA Pharma Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting	30.05.
HOOKIPA Pharma Inc. Announces Positive Clinical Data to Be Presented At the American Society for Clinical Oncology 2024 Annual Meeting	23.05.
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting	23.05.
HOOKIPA Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights	09.05.
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab	25.04.
HOOKIPA Pharma Inc. Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab	25.04.
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers	24.04.
HOOKIPA Pharma Inc. Announces FDA Clearance of Its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers	24.04.
HOOKIPA Pharma Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(4)	17.04.
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)	16.04.
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration	10.04.
HOOKIPA Pharma Inc. Announces European Medicines Agency Grant Prime Designation for the Investigational Product HB-200	10.04.
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	25.03.
HOOKIPA Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22.03.
HOOKIPA Pharma Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22.03.
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	22.03.
North American Morning Briefing : Stocks Struggle After New Records	22.03.
North American Morning Briefing : Stock Futures -2-	13.03.
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference	06.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen HOOKIPA Pharma Inc.

Aktien

A2PGMT

US43906K1007

HOOK

Andere Sprachen

Filter